Low fibrosis biomarker levels predict cardiac resynchronization therapy response (Q64115562)

object named as

Bruno Pereira

0 references

Pascal Motreff

object named as

Pascal Motreff

0 references

author name string

Grégoire Massoullié

0 references

Vincent Sapin

0 references

Sylvain Ploux

0 references

Patrick Rossignol

0 references

Aurélien Mulliez

0 references

Frédéric Jean

0 references

Pierre-Yves Marie

0 references

Charles Merlin

0 references

Marius Andronache

0 references

Xavier Chabin

0 references

Jean-Marc Sellal

0 references

Bernard Citron

0 references

Jean-René Lusson

0 references

Charles Vorilhon

0 references

Guillaume Clerfond

0 references

Pierre Bordachar

0 references

Romain Eschalier

Creative Commons Attribution 4.0 International

0 references

language of work or name

English

0 references

publication date

15 April 2019

0 references

0 references

0 references

0 references

6103

0 references

start time

15 April 2019

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

The effect of cardiac resynchronization on morbidity and mortality in heart failure

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Cardiac resynchronization in chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribut

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Association Between Midwall Late Gadolinium Enhancement and Sudden Cardiac Death in Patients With Dilated Cardiomyopathy and Mild and Moderate Left Ventricular Systolic Dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Extracellular matrix turnover biomarkers predict long-term left ventricular remodeling after myocardial infarction: insights from the REVE-2 study

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Association of galectin-3 and fibrosis markers with long-term cardiovascular outcomes in patients with heart failure, left ventricular dysfunction, and dyssynchrony: insights from the CARE-HF (Cardiac Resynchronization in Heart Failure) trial

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Impact of collagen type I turnover on the long-term response to cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Myocardial collagen metabolism in failing hearts before and during cardiac resynchronization therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

A Mediterranean diet enriched with olive oil is associated with higher serum total osteocalcin levels in elderly men at high cardiovascular risk.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Serum markers of deranged myocardial collagen turnover: their relation to malignant ventricular arrhythmias in cardioverter-defibrillator recipients with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Predictors of Response to Cardiac Resynchronization Therapy in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT)

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Focal But Not Diffuse Myocardial Fibrosis Burden Quantification Using Cardiac Magnetic Resonance Imaging Predicts Left Ventricular Reverse Modeling Following Cardiac Resynchronization Therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Pre- and intra-procedural predictors of reverse remodeling after cardiac resynchronization therapy: an MRI study

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Myocardial fibrosis: biomedical research from bench to bedside.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Circulating Biomarkers of Myocardial Fibrosis: The Need for a Reappraisal.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Plasma galectin-3 and heart failure outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy).

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Agreement is poor among current criteria used to define response to cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Serum Carboxy-Terminal Propeptide of Procollagen Type I Is a Marker of Myocardial Fibrosis in Hypertensive Heart Disease

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Cardiac interstitium in health and disease: the fibrillar collagen network

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Collagens: molecular biology, diseases, and potentials for therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Collagen cross-linking but not collagen amount associates with elevated filling pressures in hypertensive patients with stage C heart failure: potential role of lysyl oxidase

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Stu

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy.

1 reference

https://api.crossref.org/works/10.1038%2FS41598-019-42468-4

7 January 2021

Prognostic Impact of Myocardial Interstitial Fibrosis in Non-Ischemic Heart Failure - Comparison Between Preserved and Reduced Ejection Fraction Heart Failure -

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/30988339

12 December 2020